Development of the PD GeneChip: a research and diagnostic tool for Parkinson's disease

PD基因芯片的开发：​​帕金森病的研究和诊断工具

• 批准号: LP0776735
• 负责人: Prof Trevor Kilpatrick
• 金额: $ 17.95万
• 依托单位: The University of Melbourne
• 依托单位国家: 澳大利亚
• 项目类别: Linkage Projects
• 财政年份: 2007
• 资助国家: 澳大利亚
• 起止时间: 2007-07-01 至 2011-01-10
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/LP0776735
• 关键词: Development; PD; GeneChip; research; diagnostic

The PD GeneChip will provide both social and economic benefits to Australia. It will be a key research platform for Australian scientists, and will facilitate collaboration both within Australia and overseas. It will assist with health care management of PD (Parkinson's disease) patients by providing a cost-effective diagnostic tool and the possibility of predicting the clinical course of disease. This information will provide the basis for tailoring treatment to a patients needs. It is anticipated that marketing of the PD GeneChip within Australia and overseas may produce revenue of at least $40 million annually.

PD基因芯片将为澳大利亚带来社会和经济效益。它将成为澳大利亚科学家的一个重要研究平台，并将促进澳大利亚国内外的合作。它将通过提供具有成本效益的诊断工具和预测疾病临床过程的可能性来协助PD（帕金森病）患者的医疗保健管理。这些信息将为根据患者的需要进行定制治疗提供基础。预计PD基因芯片在澳大利亚和海外的销售每年可产生至少4000万美元的收入。